Perspective Therapeutics, Inc. (CATX) Reports In-Line Q2 EPS

Perspective Therapeutics, Inc. (NYSE: CATX) reported Q2 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $290 thousand versus the consensus estimate of $185.86 thousand.

For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.

You May Also Be Interested In

• Apple suing OpenAI over alleged misappropriation of trade secrets
• Niagen Bioscience files to sell up to $50M in common stock
• GuideAI Health hires firms for marketing and investor outreach